From: Chemoradiation for oesophageal cancer: the choice of treatment modality
Characteristics | Pulmonary complications | Cardiac complications | 90-day mortality | |||
---|---|---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
PTV volume | 1.00 (1.00–1.00) | 0.911 | 1.0. (1.00–1.00) | 0.960 | 1.00 (1.00–1.01) | 0.100 |
Lung V5% | 1.01 (0.93–1.10) | 0.864 | 0.96 (0.89–1.05) | 0.342 | 1.13 (0.91–1.41) | 0.265 |
Lung V20% | 1.11 (0.92–1.34) | 0.261 | 1.05 (0.86–1.28) | 0.653 | 1.10 (0.70–1.71) | 0.685 |
Mean lung dose | 0.68 (0.33–1.41) | 0.300 | 1.21 (0.57–2.55) | 0.626 | 0.43 (0.62–2.98) | 0.391 |
Heart V30% | 0.97 (0.92–1.05 | 0.665 | .96 (0.87–1.05) | 0.362 | 1.00 (0.83–1.19) | 0.965 |
Mean heart dose | 1.06 (0.91–1.23) | 0.488 | 1.07 (0.88–1.31) | 0.483 | 0.93 (o.64–1.36) | 0.709 |